14-aza prostaglandins for the treatment of glaucoma and ocular hypertension
US6160013A · kind A · utility
3Cited by
11References
23Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 30, 1999 |
| Grant date | Dec 12, 2000 |
| Priority date | — |
| Expiry date | Nov 30, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C405/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
14-Aza analogs of PGF.sub.2.alpha., PGD.sub.2, and PGE.sub.2 and methods of their use in treating glaucoma and ocular hypertension are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.